Home News Find
Call ErnesTech Today +1 888-688-2939 +1 888-688-2939   Custom Software Development at ErnesTech Email Address [email protected]  
Settings Results in 10 milliseconds

Previous Next
Aclaris Therapeutics (NASDAQ:ACRS) Trading Down 5.2%

Published 584 days ago


GENERAL
Read
AI: Article sounds Interesting
Aclaris Therapeutics (NASDAQ:ACRS) Trading Down 5.2%

Published 584 days ago


GENERAL

This solution is helpful, I Like it. Read News Collect this News Article
Aclaris Therapeutics (NASDAQ:ACRS) Trading Down 4.9%

Published 541 days ago


GENERAL
Read
AI: Article sounds Interesting
Aclaris Therapeutics (NASDAQ:ACRS) Trading Down 4.9%

Published 541 days ago


GENERAL

This solution is helpful, I Like it. Read News Collect this News Article
Short Interest in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Decreases By 9.0%

Published 691 days ago


GENERAL
Read
AI: Article sounds Interesting
Short Interest in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Decreases By 9.0%

Published 691 days ago


GENERAL

This solution is helpful, I Like it. Read News Collect this News Article
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Director Andrew N. Schiff Sells 37,839 Shares

Published 639 days ago


GENERAL
Read
AI: Article sounds Interesting
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Director Andrew N. Schiff Sells 37,839 Shares

Published 639 days ago


GENERAL

This solution is helpful, I Like it. Read News Collect this News Article
Fox Run Management L.L.C. Acquires New Stake in Aclaris Therapeutics, Inc. (NASDAQ:ACRS)

Published 522 days ago


GENERAL
Read
AI: Article sounds Interesting
Fox Run Management L.L.C. Acquires New Stake in Aclaris Therapeutics, Inc. (NASDAQ:ACRS)

Published 522 days ago


GENERAL

This solution is helpful, I Like it. Read News Collect this News Article
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Director Andrew N. Schiff Sells 7,700 Shares of Stock

Published 639 days ago


GENERAL
Read
AI: Article sounds Interesting
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Director Andrew N. Schiff Sells 7,700 Shares of Stock

Published 639 days ago


GENERAL

This solution is helpful, I Like it. Read News Collect this News Article
Aclaris Therapeutics : ATI-2138 Phase 1 SAD Preliminary Data Presentation

Published 607 days ago


GENERAL
Read
AI: Article sounds Interesting
Aclaris Therapeutics : ATI-2138 Phase 1 SAD Preliminary Data Presentation

Published 607 days ago


GENERAL

This solution is helpful, I Like it. Read News Collect this News Article
Analyst Ratings for Aclaris Therapeutics

Published 488 days ago


GENERAL
Read
AI: Article sounds Interesting
Analyst Ratings for Aclaris Therapeutics

Published 488 days ago


GENERAL

This solution is helpful, I Like it. Read News Collect this News Article
Analyst Ratings for Aclaris Therapeutics

Published 488 days ago


GENERAL
Read
AI: Article sounds Interesting
Analyst Ratings for Aclaris Therapeutics

Published 488 days ago


GENERAL

This solution is helpful, I Like it. Read News Collect this News Article
FY2022 EPS Estimates for Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Decreased by Jefferies Financial Group

Published 602 days ago


GENERAL
Read
AI: Article sounds Interesting
FY2022 EPS Estimates for Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Decreased by Jefferies Financial Group

Published 602 days ago


GENERAL

This solution is helpful, I Like it. Read News Collect this News Article
© 2024 - ErnesTech - Privacy
E-Commerce Return Policy
Call ErnesTech Today +1 (216)-435-0788 +1 (216)-435-0788   Custom Software Development at ErnesTech Email Address [email protected]